Foot and Mouth Disease Vaccines Market Size Report, 2032

Foot and Mouth Disease Vaccines Market – By Vaccine Type (Conventional [Aluminium Hydroxide & Saponin-based, Oil-based] Emergency), Animal (Cattle, Pig, Sheep & Goat), Distribution 

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Rising research &amp; development activities for animal healthcare

3.2.1.2&nbsp;&nbsp;&nbsp; Frequent FMD outbreaks

3.2.1.3&nbsp;&nbsp;&nbsp; Government initiatives and regulations

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Stringent regulatory scenario

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Reimbursement scenario

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6&nbsp;&nbsp;&nbsp; Technological landscape

3.7&nbsp;&nbsp;&nbsp; New emerging therapies

3.8&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.9&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Vaccine Type, 2021 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Conventional vaccines

5.2.1&nbsp;&nbsp;&nbsp; Aluminium hydroxide &amp; saponin-based vaccines

5.2.2&nbsp;&nbsp;&nbsp; Oil-based vaccines

5.3&nbsp;&nbsp;&nbsp; Emergency vaccines

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Animal Type, 2021 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Cattle

6.3&nbsp;&nbsp;&nbsp; Sheep &amp; Goat

6.4&nbsp;&nbsp;&nbsp; Pig

6.5&nbsp;&nbsp;&nbsp; Other animals

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Distribution Channel, 2021 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Veterinary hospitals &amp; clinics

7.3&nbsp;&nbsp;&nbsp; Government institutions

7.4&nbsp;&nbsp;&nbsp; Retail pharmacies

7.5&nbsp;&nbsp;&nbsp; Online pharmacies

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; Netherlands

8.3.7&nbsp;&nbsp;&nbsp; Rest of Europe

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; Japan

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.4.6&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.5.4&nbsp;&nbsp;&nbsp; Rest of Latin America

8.6&nbsp;&nbsp;&nbsp; Middle East and Africa

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; UAE

8.6.4&nbsp;&nbsp;&nbsp; Rest of Middle East and Africa

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Biog&eacute;nesis Bag&oacute;

9.2&nbsp;&nbsp;&nbsp; Biovet Private Ltd

9.3&nbsp;&nbsp;&nbsp; Brilliant Bio Pharma Private Limited

9.4&nbsp;&nbsp;&nbsp; BVI

9.5&nbsp;&nbsp;&nbsp; C.H. Boehringer Sohn AG &amp; Co. KG

9.6&nbsp;&nbsp;&nbsp; Ceva Sant&eacute; Animale

9.7&nbsp;&nbsp;&nbsp; Indian Immunologicals Ltd.

9.8&nbsp;&nbsp;&nbsp; Inner Mongolia Biwei Antai Biotechnology Co., Ltd.

9.9&nbsp;&nbsp;&nbsp; Kenya Veterinary Vaccines Production Institute

9.10&nbsp;&nbsp;&nbsp; Merck &amp; Co., Inc.

9.11&nbsp;&nbsp;&nbsp; MEVAC 
&nbsp;

Foot and Mouth Disease Vaccines Market

Get a free sample of this report